Clinical Trial Update: Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy

View source ↗

Summary

A Medicare-focused trial update comparing outcomes for asthma patients treated with the fluticasone propionate/salmeterol combination versus inhaled corticoster…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Advair (fluticasone propionate/salmeterol)
• Flovent (fluticasone propionate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Status: COMPLETED | Results posted: 2011-06-01